CD274 and Miyoshi myopathy: Soluble PD-L1 may also interfere with immunotherapy with PD-L1-blocking mAbs as it competes with membrane PD-L1 [61,62,63] and impairs the anti-PD-L1-mediated antibody-dependent cellular cytotoxicity (ADCC) of MM cells.